Screener
Mirum Pharmaceuticals, Inc. MIRM Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s net debt?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net debt of -$249.81M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s net debt changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net debt decreased by 40.0% year-over-year, from -$178.41M to -$249.81M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net debt?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s net debt has grown at a 12.0% compound annual growth rate (CAGR), from -$138.82M to -$244.72M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Mirum Pharmaceuticals, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude